The growth-inhibitory action of heparin on the Ehrlich ascites tumor in mice.
Sister Muriel Lippman
Abstract
Sister Muriel Lippman
Abstract
Heparin acts as a mitotic inhibitor on the Ehrlich ascites tumor in vivo , as shown by a highly significant decrease in the mitotic index following the single but not the repeated injections. This reduction in the mitotic index is reflected by tumor regression to the extent of a 40–50 per cent decrease in tumor volume. The experimental conditions employed produced no effect on the survival time of the treated animals. It is suggested that heparin exerts its effects directly on the tumor cells rather than indirectly following hemorrhage.
OpenAlex reports 37 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Heparin acts as a mitotic inhibitor on the Ehrlich ascites tumor in vivo , as shown by a highly significant decrease in the mitotic index following the single but not the repeated injections. This reduction in the mitotic index is reflected by tumor regression to the extent of a 40–50 per cent decrease in tumor volume. The experimental conditions employed produced no effect on the survival time of the treated animals. It is suggested that heparin exerts its effects directly on the tumor cells rather than indirectly following hemorrhage.
Key concepts: Ehrlich ascites, Mitotic index, Mitosis, Heparin, Ascites, In vivo, Tumor cells, Biology